NEW YORK (GenomeWeb News) — The Genome Institute of Singapore will use Illumina's BeadChip technology to analyze 3,000 samples, Illumina said today.
The Institute will work with an undisclosed pharmaceutical company as they use Illumina’s HumanRef-8 Expression. No other information was provided.
Illumina said the technology enables researchers to perform genome-wide expression profiles on eight samples on a single microarray.
The GIS said it liked that the BeadChips are from the same beadpool, which they claimed creates uniform data.
Financial terms of the agreement were not disclosed.